PT Actavis Indonesia is a pharmaceutical company that focuses on developing, manufacturing, and commercializing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. It operates a global generics business, providing patients around the globe with access to affordable medicines in approximately 80 countries. With a portfolio of more than 1,800 molecules, Actavis produces a wide range of generic products in nearly every therapeutic area and format. The company has over 110 years of experience and is a manufacturer of generic drugs, producing 120 billion tablets and capsules a year in 80 manufacturing facilities around the world. PT Actavis Indonesia integrates its generics and specialty capabilities in global research and development to meet patient needs by combining drug development capabilities with devices, services, and technologies.
Headquarters
RT 006 RW 007
East Jakarta; Jakarta;
Postal Code: 13710
Contact Details: Purchase the PT Actavis Indonesia report to view the information.
Website: http://www.actavis.co.id
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service